MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Non-Alcoholic Fatty Liver Disease

Latest Research

Latest Advance
Study
  • Condition: Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Journal: Nutrients
  • Treatment Used: Resveratrol Supplementation
  • Number of Patients: 302
  • Published —
This study evaluated the effects of resveratrol (a chemical found in red wine, red grape skins, purple grape juice, mulberries, and in smaller amounts in peanuts) supplementation in patients with non-alcoholic fatty liver disease (excessive fat build-up in the liver without another clear cause; NAFLD).
Latest Advance
Study
  • Condition: Older Women with Non-Alcoholic Fatty Liver Disease
  • Journal: Journal of bodywork and movement therapies
  • Treatment Used: Non-Linear Resistance Training and Curcumin Supplementation
  • Number of Patients: 45
  • Published —
This study examined the effects of nonlinear resistance training and curcumin supplementation in obese older women with non-alcoholic fatty liver disease.
Latest Advance
Study
  • Condition: Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Journal: International journal of molecular sciences
  • Treatment Used: Probiotics, Prebiotics, Synbiotics, Fecal Microbiome Transplantation, and Fasting-Mimicking Diet
  • Number of Patients: 0
  • Published —
This article summarized the roles of various bacterial metabolites in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and their therapeutic implications.
Latest Advance
Study
  • Condition: Liver Diseases
  • Journal: International journal of molecular sciences
  • Treatment Used: Adiponectin
  • Number of Patients: 0
  • Published —
The study researched the uses of Adiponectin between 2010 - 2020.
Latest Advance
Study
  • Condition: Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Type 2 Diabetes
  • Journal: Nutrients
  • Treatment Used: Eating Slowly
  • Number of Patients: 308
  • Published —
This study evaluated eating speed in men and women with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM).
Latest Advance
Study
  • Condition: Premenopausal Breast Cancer
  • Journal: BMC cancer
  • Treatment Used: Toremifene (TOR) vs. Tamoxifen (TAM)
  • Number of Patients: 92
  • Published —
This study compared the safety of toremifene (TOR) versus tamoxifen (TAM) in the adjuvant treatment of pre-menopausal patients with breast cancer.
Latest Advance
Study
  • Condition: Deferasirox-Induced Liver Injury and Fanconi Syndrome in Male Patient with Beta-Thalassemia Major
  • Journal: BMJ case reports
  • Treatment Used: Cessation of Deferasirox
  • Number of Patients: 1
  • Published —
This case report discusses a Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male patient.
Latest Advance
Study
  • Condition: Obesity and Metabolic Disorders
  • Journal: United European gastroenterology journal
  • Treatment Used: Endoscopic Bariatric and Metabolic Therapies (EBMTs)
  • Number of Patients: 0
  • Published —
This article discusses the current evidence on endoscopic bariatric (weight loss) and metabolic therapies (EBMTs) in the treatment of obesity and metabolic disorders.
Latest Advance
Study
  • Condition: COVID-19
  • Journal: Cell metabolism
  • Treatment Used: Statins
  • Number of Patients: 13981
  • Published —
In this study, researchers evaluated the outcomes of taking statins while being treated for COVID-19.
Latest Advance
Study
  • Condition: Chronic Viral Hepatitis C
  • Journal: Scientific reports
  • Treatment Used: Interferon-Free Treatment
  • Number of Patients: 20
  • Published —
This study tested the safety and efficacy of using interferon-free treatment to treat patients with chronic viral hepatitis C infections.
Latest Advance
Study
  • Condition: Advanced Hepatocellular Carcinoma (HCC) with Cirrhosis or Nonalcoholic Steatohepatitis or Liver Metastases
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: MTL-CEBPA
  • Number of Patients: 38
  • Published —
This study considered patients with advanced hepatocellular carcinoma (advanced liver cancer; HCC) who also have cirrhosis or nonalcoholic steatohepatitis (buildup of fat in the liver) or liver metastases (tumors in the liver) in order to analyze the safety and effectiveness of MTL-CEBPA.
Latest Advance
Study
  • Condition: Diabetes with Chronic Hepatitis B
  • Journal: Journal of viral hepatitis
  • Treatment Used: Thiazolidinediones
  • Number of Patients: 28999
  • Published —
The study researched the outcomes of Thiazolidinediones in patients with diabetes with chronic hepatitis B.
Showing 1–12 of 202 Latest Research
Next